1 / 10

IAPCOI perspectives on Rotavirus vaccines: What are the issues?

IAPCOI perspectives on Rotavirus vaccines: What are the issues?. Vipin M. Vashishtha, MD, FIAP Convener, IAPCOI 2011-13 vipinipsita@gmail.com. Do we have significant disease burden to warrant universal immunization ag rotavirus?

amber-petty
Télécharger la présentation

IAPCOI perspectives on Rotavirus vaccines: What are the issues?

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. IAPCOI perspectives on Rotavirus vaccines: What are the issues? Vipin M. Vashishtha, MD, FIAP Convener, IAPCOI 2011-13 vipinipsita@gmail.com

  2. Do we have significant disease burden to warrant universal immunization ag rotavirus? • Are the available vaccines potent enough to provide adequate protection?

  3. Efficacy of RV vaccines in India • OPV fared poorly only in India!!!

  4. What ought to be the schedule of using RV in India? • Do we need to adopt 3-dose series of all RV vaccines? • Do we need to use these vaccines differently to get most out of them? • What about catch-up schedule?

  5. How effectively current RV vaccine going to provide homotypic & heterotypic protection?

  6. Whether vaccination may lead to the replacement of vaccine-type strains??

  7. What about the risks of intussusceptions ?

  8. Are the current vaccines indeed cost-effective? • What is the status of Indian RV vaccine? • Should we wait till the results of Rotvac TM are available?

More Related